The level of serum CK, CKMB and cTnI of wistar rats after ADM chemotherapy were decreased with vasorel treatment,with during anaesthetic stage,it indicated that vasorel may restrain myocardial damage after ADM chemotherapy and it protect myocardium during anaesthesia stage.
万爽力干预治疗后Wistar大鼠cTnI水平降低,提示万爽力可抑制ADM导致的心肌损伤的进一步加重,在围麻醉期具有一定的心肌保护作用。
参考来源 - 万爽力对阿霉素化疗后大鼠围麻醉期心肌肌钙蛋白Ⅰ影响的实验研究·2,447,543篇论文数据，部分数据来源于NoteExpress
Conclusion Long-term administration of VASOREL has favorable clinical tolerability and safety for CHD patients.
结论冠心病患者长期服用曲美他嗪的临床耐受性和安全性良好。
Results the trial was completed in 95% of the patients, 2 patients withdrew in the VASOREL group and 4 patients in the control group; but none for the intolerable therapy.
结果试验总完成率95%，其中治疗组2例、对照组4例脱落，无患者因不耐受药物而脱落。
应用推荐